The Journal of Pediatrics
Volume 157, Issue 5 , Pages 704-714 , November 2010

Eczema in Early Life: Genetics, the Skin Barrier, and Lessons Learned from Birth Cohort Studies

  • Jocelyn M. Biagini Myers, PhD

      Affiliations

    • Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
    • ,
  • Gurjit K. Khurana Hershey, MD, PhD

      Affiliations

    • Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
    • Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
    • Corresponding Author InformationReprint requests: Gurjit K. Khurana Hershey, MD, PhD, Division of Asthma Research, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, MLC 7037, Cincinnati, OH 45229-7037.

Received 13 August 2009 ,Revised 22 April 2010 ,Accepted 6 July 2010.

References 

  1. Bieber T. Atopic dermatitis. N Engl J Med. 2008 Apr 3;358:1483–1494
  2. Cork MJ, Robinson DA, Vasilopoulos Y, Ferguson A, Moustafa M, MacGowan A, et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol. 2006;118:3–21quiz 2–3
  3. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004;113:832–836
  4. Williams H, Flohr C. How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol. 2006;118:209–213
  5. Williams H, Stewart A, von Mutius E, Cookson W, Anderson HR. Is eczema really on the increase worldwide?. J Allergy Clin Immunol. 2008;121:947–954e15
  6. Strachan D, Sibbald B, Weiland S, Ait-Khaled N, Anabwani G, Anderson HR, et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol. 1997;8:161–176
  7. Williams HC. Atopic dermatitis—the epidemiology, causes and prevention of atopic eczema. Cambridge: Cambridge University Press; 2000;
  8. In:  Shelov SP,  Hannemann R editor. Caring for your baby and young child: birth to age 5. The complete and authoritative guide. 4th ed. New York: Bantam Books; 2004;
  9. Brown S, Reynolds NJ. Atopic and non-atopic eczema. BMJ. 2006;332:584–588
  10. Boguniewicz M, Leung DY. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol. 2010;125:4–13quiz 4–5
  11. Boguniewicz M, Leung DY. 10. Atopic dermatitis. J Allergy Clin Immunol. 2006;117(2 Suppl Mini-Primer):S475–S480
  12. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347:1151–1160
  13. Leung DY. Our evolving understanding of the functional role of filaggrin in atopic dermatitis. J Allergy Clin Immunol. 2009;124:494–495
  14. Matsuoka S, Nakayama R, Nakayama H, Yamashita K, Kuroda Y. Prevalence of specific allergic diseases in school children as related to parental atopy. Pediatrics Int. 2002;41:46–51
  15. Wadonda-Kabondo N, Sterne JA, Golding J, Kennedy CT, Archer CB, Dunnill MG. Association of parental eczema, hayfever, and asthma with atopic dermatitis in infancy: birth cohort study. Arch Dis Child. 2004;89:917–921
  16. Larsen FS, Holm NV, Henningsen K. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol. 1986;15:487–494
  17. Schultz Larsen F. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. Am Acad Dermatol. 1993;28(5 part 1):719–723
  18. Cookson WO, Ubhi B, Lawrence R, Abecasis GR, Walley AJ, Cox HE, et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet. 2001;27:372–373
  19. Lee YA, Wahn U, Kehrt R, Tarani L, Businco L, Gustafsson D, et al. A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nat Genet. 2000;26:470–473
  20. Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol. 2004;4:978–988
  21. Haagerup A, Bjerke T, Schiotz PO, Dahl R, Binderup HG, Tan Q, et al. Atopic dermatitis—a total genome-scan for susceptibility genes. Acta Derm Venereol. 2004;84:346–352
  22. Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, Leung DY. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol. 2003;112:1195–1202
  23. Vickery BP. Skin barrier function in atopic dermatitis. Curr Opin Pediatr. 2007;19:89–93
  24. Brown SJ, Irvine AD. Atopic eczema and the filaggrin story. Semin Cutan Med Surg. 2008;27:128–137
  25. Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol. 2009;129:1892–1908
  26. Bieber T, Novak N. Pathogenesis of atopic dermatitis: new developments. Curr Allergy Asthma Rep. 2009;9:291–294
  27. Barnes KC. An update on the genetics of atopic dermatitis: scratching the surface in 2009. J Allergy Clin Immunol. 2010;125:16–29e1-11; quiz 30–31
  28. Greisenegger E, Novak N, Maintz L, Bieber T, Zimprich F, Haubenberger D, et al. Analysis of four prevalent filaggrin mutations (R501X, 2282del4, R2447X and S3247X) in Austrian and German patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2010;24:607–610
  29. McGrath JA, Uitto J. The filaggrin story: novel insights into skin-barrier function and disease. Trends Mol Med. 2008;14:20–27
  30. Weidinger S, Baurecht H, Wagenpfeil S, Henderson J, Novak N, Sandilands A, et al. Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk. J Allergy Clin Immunol. 2008;122:560–568e4
  31. McKinley-Grant LJ, Idler WW, Bernstein IA, Parry DA, Cannizzaro L, Croce CM, et al. Characterization of a cDNA clone encoding human filaggrin and localization of the gene to chromosome region 1q21. Proc Natl Acad Sci U S A. 1989;86:4848–4852
  32. Gan SQ, McBride OW, Idler WW, Markova N, Steinert PM. Organization, structure, and polymorphisms of the human profilaggrin gene. Biochemistry. 1990;29:9432–9440
  33. Smith FJ, Irvine AD, Terron-Kwiatkowski A, Sandilands A, Campbell LE, Zhao Y, et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet. 2006;38:337–342
  34. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38:441–446
  35. Barker JN, Palmer CN, Zhao Y, Liao H, Hull PR, Lee SP, et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol. 2007;127:564–567
  36. Burgess JA, Lowe AJ, Matheson MC, Varigos G, Abramson MJ, Dharmage SC. Does eczema lead to asthma?. J Asthma. 2009;46:429–436
  37. Marenholz I, Nickel R, Ruschendorf F, Schulz F, Esparza-Gordillo J, Kerscher T, et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol. 2006;118:866–871
  38. Henderson J, Northstone K, Lee SP, Liao H, Zhao Y, Pembrey M, et al. The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J Allergy Clin Immunol. 2008;121:872–877e9
  39. Weidinger S, O'Sullivan M, Illig T, Baurecht H, Depner M, Rodriguez E, et al. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol. 2008;121:1203–1209e1
  40. Brown SJ, Relton CL, Liao H, Zhao Y, Sandilands A, Wilson IJ, et al. Filaggrin null mutations and childhood atopic eczema: a population-based case-control study. J Allergy Clin Immunol. 2008;121:940–946e3
  41. Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol. 2007;120:150–155
  42. O'Regan GM, Sandilands A, McLean WH, Irvine AD. Filaggrin in atopic dermatitis. J Allergy Clin Immunol. 2009;124(3 Suppl. 2):R2–R6
  43. Walley AJ, Chavanas S, Moffatt MF, Esnouf RM, Ubhi B, Lawrence R, et al. Gene polymorphism in Netherton and common atopic disease. Nat Genet. 2001;29:175–178
  44. O'Regan GM, Sandilands A, McLean WH, Irvine AD. Filaggrin in atopic dermatitis. J Allergy Clin Immunol. 2008;122:689–693
  45. Kato A, Fukai K, Oiso N, Hosomi N, Murakami T, Ishii M. Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population. Br J Dermatol. 2003;148:665–669
  46. Kawashima T, Noguchi E, Arinami T, Yamakawa-Kobayashi K, Nakagawa H, Otsuka F, et al. Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. J Med Genet. 1998;35:502–504
  47. Rafatpanah H, Bennett E, Pravica V, McCoy MJ, David TJ, Hutchinson IV, et al. Association between novel GM-CSF gene polymorphisms and the frequency and severity of atopic dermatitis. J Allergy Clin Immunol. 2003;112:593–598
  48. Kiyohara C, Tanaka K, Miyake Y. Genetic susceptibility to atopic dermatitis. Allergol Int. 2008;57:39–56
  49. He JQ, Chan-Yeung M, Becker AB, Dimich-Ward H, Ferguson AC, Manfreda J, et al. Genetic variants of the IL13 and IL4 genes and atopic diseases in at-risk children. Genes Immun. 2003;4:385–389
  50. Sehra S, Yao Y, Howell MD, Nguyen ET, Kansas GS, Leung DY, et al. IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation. J Immunol. 2010;184:3186–3190
  51. Howell MD, Gallo RL, Boguniewicz M, Jones JF, Wong C, Streib JE, et al. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity. 2006;24:341–348
  52. Kim BE, Leung DY, Boguniewicz M, Howell MD. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol. 2008;126:332–337
  53. An update on the genetics of atopic dermatitis: scratching the surface in 2009. J Allergy Clin Dermatol. 2010;125:16–29e1-11
  54. Tsunemi Y, Saeki H, Nakamura K, Sekiya T, Hirai K, Kakinuma T, et al. Interleukin-13 gene polymorphism G4257A is associated with atopic dermatitis in Japanese patients. J Dermatol Sci. 2002;30:100–107
  55. Liu X, Nickel R, Beyer K, Wahn U, Ehrlich E, Freidhoff LR, et al. An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). J Allergy Clin Immunol. 2000;106(1 Pt 1):167–170
  56. Hummelshoj T, Bodtger U, Datta P, Malling HJ, Oturai A, Poulsen LK, et al. Association between an interleukin-13 promoter polymorphism and atopy. Eur J Immunogenet. 2003;30:355–359
  57. Hoffjan S, Ostrovnaja I, Nicolae D, Newman DL, Nicolae R, Gangnon R, et al. Genetic variation in immunoregulatory pathways and atopic phenotypes in infancy. J Allergy Clin Immunol. 2004;113:511–518
  58. Van der Pouw Kraan TCTM, Van der Zee JS, Boeije LCM, de Groot ER, Stapel SO, Aarden LA. The role of IL-13 in IgE synthesis by allergic asthma patients. Clin Exp Allergy. 1998;111:129–135
  59. Callard RE, Hamvas R, Chatterton C, Blanco C, Pembrey M, Jones R, et al. An interaction between the IL-4R alpha gene and infection is associated with atopic eczema in young children. Clin Exp Allergy. 2002;32:990–993
  60. Oiso N, Fukai K, Ishii M. Interleukin 4 receptor alpha chain polymorphism Gln551Arg is associated with adult atopic dermatitis in Japan. Br J Dermatol. 2000;142:1003–1006
  61. Hosomi N, Fukai K, Oiso N, Kato A, Ishii M, Kunimoto H, et al. Polymorphisms in the promoter of the interleukin-4 receptor alpha chain gene are associated with atopic dermatitis in Japan. J Invest Dermatol. 2004;122:843–845
  62. Soderhall C, Bradley M, Kockum I, Luthman H, Wahlgren CF, Nordenskjold M. Analysis of association and linkage for the interleukin-4 and interleukin-4 receptor b;alpha; regions in Swedish atopic dermatitis families. Clin Exp Allergy. 2002;32:1199–1202
  63. Novak N, Kruse S, Kraft S, Geiger E, Kluken H, Fimmers R, et al. Dichotomic nature of atopic dermatitis reflected by combined analysis of monocyte immunophenotyping and single nucleotide polymorphisms of the interleukin-4/interleukin-13 receptor gene: the dichotomy of extrinsic and intrinsic atopic dermatitis. J Invest Dermatol. 2002;119:870–875
  64. Yamamoto N, Sugiura H, Tanaka K, Uehara M. Heterogeneity of interleukin 5 genetic background in atopic dermatitis patients: significant difference between those with blood eosinophilia and normal eosinophil levels. J Dermatol Sci. 2003;33:121–126
  65. Saarinen J, Kalkkinen N, Welgus HG, Kovanen PT. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J Biol Chem. 1994;269:18134–18140
  66. Kofford MW, Schwartz LB, Schechter NM, Yager DR, Diegelmann RF, Graham MF. Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide. J Biol Chem. 1997;272:7127–7131
  67. Taipale J, Lohi J, Saarinen J, Kovanen PT, Keski-Oja J. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem. 1995;270:4689–4696
  68. Mao XQ, Shirakawa T, Enomoto T, Shimazu S, Dake Y, Kitano H, et al. Association between variants of mast cell chymase gene and serum IgE levels in eczema. Hum Hered. 1998;48:38–41
  69. Weidinger S, Rummler L, Klopp N, Wagenpfeil S, Baurecht HJ, Fischer G, et al. Association study of mast cell chymase polymorphisms with atopy. Allergy. 2005;60:1256–1261
  70. Mao XQ, Shirakawa T, Yoshikawa T, Yoshikawa K, Kawai M, Sasaki S, et al. Association between genetic variants of mast-cell chymase and eczema. Lancet. 1996;348:581–583
  71. Kawashima T, Noguchi E, Arinami T, Kobayashi K, Otsuka F, Hamaguchi H. No evidence for an association between a variant of the mast cell chymase gene and atopic dermatitis based on case-control and haplotype-relative-risk analyses. Hum Hered. 1998;48:271–274
  72. Tanaka K, Sugiura H, Uehara M, Sato H, Hashimoto-Tamaoki T, Furuyama J. Association between mast cell chymase genotype and atopic eczema: comparison between patients with atopic eczema alone and those with atopic eczema and atopic respiratory disease. Clin Exp Allergy. 1999;29:800–803
  73. Badertscher K, Bronnimann M, Karlen S, Braathen LR, Yawalkar N. Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis. Arch Dermatol Res. 2005;296:503–506
  74. Dobrovolskaia MA, Vogel SN. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect. 2002;4:903–914
  75. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990;249:1431–1433
  76. Triantafilou M, Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 2002;23:301–304
  77. Biagini Myers JM, Wang N, Lemasters GK, Bernstein DI, Epstein TG, Lindsey MA, et al. Genetic and environmental risk factors for childhood eczema development and allergic sensitization in the CCAAPS cohort. J Invest Dermatol. 2010;130:430–437
  78. Lange J, Heinzmann A, Zehle C, Kopp M. CT genotype of promotor polymorphism C159T in the CD14 gene is associated with lower prevalence of atopic dermatitis and lower IL-13 production. Pediatr Allergy Immunol. 2005;16:456–457
  79. Gern JE, Reardon CL, Hoffjan S, Nicolae D, Li Z, Roberg KA, et al. Effects of dog ownership and genotype on immune development and atopy in infancy. J Allergy Clin Immunol. 2004;113:307–314
  80. Litonjua AA, Belanger K, Celedon JC, Milton DK, Bracken MB, Kraft P, et al. Polymorphisms in the 5' region of the CD14 gene are associated with eczema in young children. J Allergy Clin Immunol. 2005;115:1056–1062
  81. Sugarman JL. The epidermal barrier in atopic dermatitis. Semin Cutan Med Surg. 2008;27:108–114
  82. Cork M. The importance of skin barrier function. J Dermatol Treatment. 1997;8:S7–13
  83. Ong PY, Leung DY. Immune dysregulation in atopic dermatitis. Curr Allergy Asthma Rep. 2006;6:384–389
  84. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;92(suppl):44–47
  85. Gupta J, Grube E, Ericksen MB, Stevenson MD, Lucky AW, Sheth AP, et al. Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity. J Allergy Clin Immunol. 2008;121:725–730e2
  86. Nemoto-Hasebe I, Akiyama M, Nomura T, Sandilands A, McLean WH, Shimizu H. Clinical severity correlates with impaired barrier in filaggrin-related eczema. J Invest Dermatol. 2009;129:682–689
  87. Hudson TJ. Skin barrier function and allergic risk. Nat Genet. 2006;38:399–400
  88. Braff MH, Gallo RL. Antimicrobial peptides: an essential component of the skin defensive barrier. Curr Top Microbiol Immunol. 2006;306:91–110
  89. McGirt LY, Beck LA. Innate immune defects in atopic dermatitis. J Allergy Clin Immunol. 2006;118:202–208
  90. Wahn U. The allergic march. Berlin, Germany: World Allergy Organization; 2007;
  91. Kramer U, Lemmen CH, Behrendt H, Link E, Schafer T, Gostomzyk J, et al. The effect of environmental tobacco smoke on eczema and allergic sensitization in children. Br J Dermatol. 2004;150:111–118
  92. Schafer T, Dirschedl P, Kunz B, Ring J, Uberla K. Maternal smoking during pregnancy and lactation increases the risk for atopic eczema in the offspring. J Am Acad Dermatol. 1997;36:550–556
  93. Wang IJ, Hsieh WS, Wu KY, Guo YL, Hwang YH, Jee SH, et al. Effect of gestational smoke exposure on atopic dermatitis in the offspring. Pediatr Allergy Immunol. 2008;19:580–586
  94. Miyake Y, Ohya Y, Tanaka K, Yokoyama T, Sasaki S, Fukushima W, et al. Home environment and suspected atopic eczema in Japanese infants: the Osaka Maternal and Child Health Study. Pediatr Allergy Immunol. 2007;18:425–432
  95. Magnusson LL, Olesen AB, Wennborg H, Olsen J. Wheezing, asthma, hayfever, and atopic eczema in childhood following exposure to tobacco smoke in fetal life. Clin Exp Allergy. 2005;35:1550–1556
  96. Noakes P, Taylor A, Hale J, Breckler L, Richmond P, Devadason SG, et al. The effects of maternal smoking on early mucosal immunity and sensitization at 12 months of age. Pediatr Allergy Immunol. 2007;18:118–127
  97. Muizzuddin N, Marenus K, Vallon P, Maes D. Effect of cigarette smoke on skin. J Soc Cosmet Chem. 1997;48:235–242
  98. Mimura J, Yamashita K, Nakamura K, Morita M, Takagi TN, Nakao K, et al. Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells. 1997;2:645–654
  99. Tauchi M, Hida A, Negishi T, Katsuoka F, Noda S, Mimura J, et al. Constitutive expression of aryl hydrocarbon receptor in keratinocytes causes inflammatory skin lesions. Mol Cell Biol. 2005;25:9360–9368
  100. Flohr C, Pascoe D, Williams HC. Atopic dermatitis and the “hygiene hypothesis”: too clean to be true?. Br J Dermatol. 2005;152:202–216
  101. McNally NJ, Williams HC, Phillips DR, Strachan DP. Is there a geographical variation in eczema prevalence in the UK? Evidence from the 1958 British Birth Cohort Study. Br J Dermatol. 2000;142:712–720
  102. McKeever TM, Lewis SA, Smith C, Collins J, Heatlie H, Frischer M, et al. Siblings, multiple births, and the incidence of allergic disease: a birth cohort study using the West Midlands general practice research database. Thorax. 2001;56:758–762
  103. Karmaus W, Botezan C. Does a higher number of siblings protect against the development of allergy and asthma? A review. J Epidemiol Community Health. 2002;56:209–217
  104. Williams HC, Strachan DP, Hay RJ. Childhood eczema: disease of the advantaged?. BMJ. 1994;308:1132–1135
  105. Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989;299:1259–1260
  106. Loza MJ, Peters SP, Penn RB. Atopy, asthma, and experimental approaches based on the linear model of T cell maturation. Clin Exp Allergy. 2005;35:8–17
  107. Langan SM, Flohr C, Williams HC. The role of furry pets in eczema: a systematic review. Arch Dermatol. 2007;143:1570–1577
  108. Wang M, Karlsson C, Olsson C, Adlerberth I, Wold AE, Strachan DP, et al. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol. 2008;121:129–134
  109. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol. 2001;108:516–520
  110. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol. 2001;107:129–134
  111. Penders J, Thijs C, van den Brandt PA, Kummeling I, Snijders B, Stelma F, et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut. 2007;56:661–667
  112. Kulig M, Bergmann R, Klettke U, Wahn V, Tacke U, Wahn U. Natural course of sensitization to food and inhalant allergens during the first 6 years of life. J Allergy Clin Immunol. 1999;103:1173–1179
  113. Lau S, Nickel R, Niggemann B, Gruber C, Sommerfeld C, Illi S, et al. The development of childhood asthma: lessons from the German Multicentre Allergy Study (MAS). Paediatr Respir Rev. 2002;3:265–272
  114. Ohshima Y, Yamada A, Hiraoka M, Katamura K, Ito S, Hirao T, et al. Early sensitization to house dust mite is a major risk factor for subsequent development of bronchial asthma in Japanese infants with atopic dermatitis: results of a 4-year followup study. Ann Allergy Asthma Immunol. 2002;89:265–270
  115. van der Hulst AE, Klip H, Brand PLP. Risk of developing asthma in young children with atopic eczema: a systematic review. J Allergy Clin Immunol. 2007;120:565–569
  116. Host A, Halken S, Jacobsen HP, Christensen AE, Herskind AM, Plesner K. Clinical course of cow's milk protein allergy/intolerance and atopic diseases in childhood. Pediatr Allergy Immunol. 2002;13(Suppl. 15):23–28
  117. Golding J. The Avon Longitudinal Study of Parents and Children (ALSPAC)—study design and collaborative opportunities. Eur J Endocrinol. 2004;151(Suppl. 3):U119–U123
  118. Pembrey M. The Avon Longitudinal Study of Parents and Children (ALSPAC): a resource for genetic epidemiology. Eur J Endocrinol. 2004;151(Suppl. 3):U125–U129
  119. Emenius G, Pershagen G, Berglind N, Kwon HJ, Lewne M, Nordvall SL, et al. NO2, as a marker of air pollution, and recurrent wheezing in children: a nested case-control study within the BAMSE birth cohort. Occup Environ Med. 2003;60:876–881
  120. Mai XM, Neuman A, Ostblom E, Pershagen G, Nordvall L, Almqvist C, et al. Symptoms to pollen and fruits early in life and allergic disease at 4 years of age. Allergy. 2008;63:1499–1504
  121. Wickman M, Kull I, Pershagen G, Nordvall SL. The BAMSE project: presentation of a prospective longitudinal birth cohort study. Pediatr Allergy Immunol. 2002;13(Suppl. 15):11–13
  122. Kull I, Bohme M, Wahlgren CF, Nordvall L, Pershagen G, Wickman M. Breast-feeding reduces the risk for childhood eczema. J Allergy Clin Immunol. 2005;116:657–661
  123. Mai XM, Almqvist C, Nilsson L, Wickman M. Birth anthropometric measures, body mass index and allergic diseases in a birth cohort study (BAMSE). Arch Dis Child. 2007;92:881–886
  124. Arshad SH, Hide DW. Effect of environmental factors on the development of allergic disorders in infancy. J Allergy Clin Immunol. 1992;90:235–241
  125. Wijga A, Smit HA, Brunekreef B, Gerritsen J, Kerkhof M, Koopman LP, et al. Are children at high familial risk of developing allergy born into a low risk environment? The PIAMA Birth Cohort Study. Prevention and Incidence of Asthma and Mite Allergy. Clin Exp Allergy. 2001;31:576–581
  126. Lodrup Carlsen KC. The environment and childhood asthma (ECA) study in Oslo: ECA-1 and ECA-2. Pediatr Allergy Immunol. 2002;13(Suppl. 15):29–31
  127. Laubereau B, Brockow I, Zirngibl A, Koletzko S, Gruebl A, von Berg A, et al. Effect of breast-feeding on the development of atopic dermatitis during the first 3 years of life–results from the GINI-birth cohort study. J Pediatr. 2004;144:602–607
  128. Heinrich J, Bolte G, Holscher B, Douwes J, Lehmann I, Fahlbusch B, et al. Allergens and endotoxin on mothers' mattresses and total immunoglobulin E in cord blood of neonates. Eur Respir J. 2002;20:617–623
  129. Devereux G, Barker RN, Seaton A. Antenatal determinants of neonatal immune responses to allergens. Clin Exp Allergy. 2002;32:43–50
  130. Kurukulaaratchy R, Fenn M, Matthews S, Hasan Arshad S. The prevalence, characteristics of and early life risk factors for eczema in 10-year-old children. Pediatr Allergy Immunol. 2003;14:178–183
  131. Kerkhof M, Koopman LP, van Strien RT, Wijga A, Smit HA, Aalberse RC, et al. Risk factors for atopic dermatitis in infants at high risk of allergy: the PIAMA study. Clin Exp Allergy. 2003;33:1336–1341
  132. Brockow I, Zutavern A, Hoffmann U, Grubl A, von Berg A, Koletzko S, et al. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. J Investig Allergol Clin Immunol. 2009;19:180–187
  133. Filipiak B, Zutavern A, Koletzko S, von Berg A, Brockow I, Grubl A, et al. Solid food introduction in relation to eczema: results from a four-year prospective birth cohort study. J Pediatr. 2007;151:352–358
  134. Morgenstern V, Zutavern A, Cyrys J, Brockow I, Koletzko S, Kramer U, et al. Atopic diseases, allergic sensitization, and exposure to traffic-related air pollution in children. Am J Respir Crit Care Med. 2008;177:1331–1337
  135. Sausenthaler S, Kompauer I, Borte M, Herbarth O, Schaaf B, Berg A, et al. Margarine and butter consumption, eczema and allergic sensitization in children. The LISA birth cohort study. Pediatr Allergy Immunol. 2006;17:85–93
  136. Bockelbrink A, Heinrich J, Schafer I, Zutavern A, Borte M, Herbarth O, et al. Atopic eczema in children: another harmful sequel of divorce. Allergy. 2006;61:1397–1402
  137. Martindale S, McNeill G, Devereux G, Campbell D, Russell G, Seaton A. Antioxidant intake in pregnancy in relation to wheeze and eczema in the first two years of life. Am J Respir Crit Care Med. 2005;171:121–128
  138. Seaton A, Godden DJ, Brown K. Increase in asthma: a more toxic environment or a more susceptible population?. Thorax. 1994;49:171–174
  139. Nickel R, Lau S, Niggemann B, Gruber C, von Mutius E, Illi S, et al. Messages from the German Multicentre Allergy Study. Pediatr Allergy Immunol. 2002;13(Suppl. 15):7–10
  140. Bergmann RL, Bergmann KE, Lau-Schadensdorf S, Luck W, Dannemann A, Bauer CP, et al. Atopic diseases in infancy. The German multicenter atopy study (MAS-90). Pediatr Allergy Immunol. 1994;5(6 Suppl):19–25
  141. Illi S, von Mutius E, Lau S, Nickel R, Gruber C, Niggemann B, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol. 2004;113:925–931
  142. von Mutius E. The “atopic march”: MAS study. Revue Française d'Allergologie et d'Immunologie Clinique. 2003;43:427–430
  143. Bufford JD, Reardon CL, Li Z, Roberg KA, Dasilva D, Eggleston PA, et al. Effects of dog ownership in early childhood on immune development and atopic diseases. Clin Exp Allergy. 2008;38:1635–1643
  144. Lemanske RF. The childhood origins of asthma (COAST) study. Pediatr Allergy Immunol. 2002;13(Suppl. 15):38–43
  145. Singh A, Gangnon R, Evans M, Roberg KA, Tisler C, Da Silva DF, et al. Risk factors for the persistent expression of atopic dermatitis in a high risk birth cohort [abstract]. J Allergy Clin Immunol. 2006;117:S178
  146. Shanovich KM, Evans MD, Tisler CJ, Roberg KA, Anderson EL, Pappas TE, et al. The amount of food-specific IgE at age 1 year is associated with the risk of asthma at age 6 years [abstract]. J Allergy Clin Immunol. 2008;121:S238
  147. Tisler CJ, Roberg KA, Anderson EL, Salazar LE, Grabher RA, DaSilva DF, et al. Asthma at age 6 is associated with an early and variable pattern of allergic sensitization in shildhood [abstract]. J Allergy Clin Immunol. 2007;119:S69
  148. Virnig CM, Roberg K, Anderson E, Salazar LEP, Grabher RA, Tisler C, et al. Allergen sensitization as a predictor of wheezing phenotype at age six years [abstract]. J Allergy Clin Immunol. 2007;119:S69
  149. LeMasters GK, Wilson K, Levin L, Biagini J, Ryan P, Lockey JE, et al. High prevalence of aeroallergen sensitization among infants of atopic parents. J Pediatr. 2006;149:505–511
  150. Schroer KT, Biagini Myers JM, Ryan PH, Lemasters GK, Bernstein DI, Villareal M, et al. Associations between multiple environmental exposures and glutathione S-transferase P1 on persistent wheezing in a birth cohort. J Pediatr. 2009;154:401–408
  151. Gern JE, Visness CM, Gergen PJ, Wood RA, Bloomberg GR, O'Connor GT, et al. The Urban Environment and Childhood Asthma (URECA) birth cohort study: design, methods, and study population. BMC Pulm Med. 2009;9:17

 Supported by the National Institute of Environmental Health Sciences (R01 ES11170 and R01 AR054490 to G.K.H.). The authors report no conflicts of interest.

PII: S0022-3476(10)00587-1

doi: 10.1016/j.jpeds.2010.07.009

The Journal of Pediatrics
Volume 157, Issue 5 , Pages 704-714 , November 2010

Article Tools